Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 524394 | NSE Symbol : VIMTALABS | ISIN : INE579C01029 | Industry : Healthcare |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
20-Jan-2025	24-Jan-2025	Quarterly Results	Quarterly Results VIMTA LABS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2025 ,inter alia, to consider and approve Board Meeting Intimation for the third quarter ended 31st December, 2024 is scheduled to held on Friday, 24th January, 2025. The Board of Directors in their meeting held today, have approved unaudited financial results for the quarter ended 31st December,2024 and appointed Chief Financial Officer. (As Per BSE Announcement Dated on: 24/01/2025)
04-Nov-2024	08-Nov-2024	Quarterly Results	VIMTA LABS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2024 inter alia to consider and approve interalia and take on record the standalone unaudited financial results and consolidated unaudited financial results for the second quarter/half year ended 30th September 2024. Pursuant to Regulation 33 of the SEBI (LODR) Regulation,2015 standalone and consolidated unaudited Financial Results for the 2nd quarter/half year ended 30th September 2024. (As Per BSE Announcement dated on 08.11.2024)
11-Jul-2024	17-Jul-2024	Quarterly Results	VIMTA LABS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/07/2024 inter alia to consider and approve NOTICE is hereby given pursuant to regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday 17th July 2024 to consider approve and take on record the standalone unaudited financial results and consolidated unaudited financial results for the first quarter ended 30th June 2024. Further as per the SEBI (Prohibition of Insider Trading) Regulations 2015 and in accordance to the code of conduct of the Company the Trading window closure period has commenced from 01st July 2024 and will remain closed till 48 hours after the announcement of financial results of the company to the stock exchange. Copy of the Notice is available in the companys website i.e. https://vimta.com/notices/ Standalone & Consolidated Unaudited financial results of the 1st Quarter (As Per BSE Announcement dated on 17.07.2024)
08-May-2024	18-May-2024	Final Dividend	VIMTA LABS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2024 inter alia to consider and approve The standalone and consolidated audited financial results for the fourth quarter and year ended 31st March 2024 and to consider and recommend the payment of dividend if any on equity shares of the Company for the Financial Year ended 31st March 2024. Audited standalone and consolidated financial results for the 4th quarter and financial year ended 31st march 2024. Audited standalone and consolidated financial results for the 4th quarter ended and year ended 31.03.2024. Recommendation of Dividend. (As per BSE Announcement Dated on 18/05/2024)
20-Mar-2024	30-Mar-2024	Scheme of Amalgamation	VIMTA LABS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2024 inter alia to consider and approve the scheme of amalgamation of Emtac Laboratories Private Limited Wholly Owned Subsidiary Company with Vimta Labs Limitedholding company. Approval of Scheme of Amalgamation of Emtac Laboratories Private Limited, Wholly Owned Subsidiary Company with Vimta Labs Limited, Holding Company. (As Per BSE Announcement Dated on 30.03.2024)
19-Jan-2024	31-Jan-2024	Quarterly Results	VIMTA LABS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve the standalone unaudited financial results and consolidated unaudited financial results for the third quarter ended 31st December 2023. Standalone and Consolidated Unaudited Financial Results for the Third Quarter ended 31st December 2023 along with Limited Review Report. Reappointment of Independent Directors Reappointment of Managing Director, Executive Director-Operations and Executive Director. (As Per BSE Announcement Dated on 31/01/2024)
18-Oct-2023	30-Oct-2023	Quarterly Results	VIMTA LABS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2023 inter alia to consider and approve and take on record the standalone unaudited financial results and consolidated financial results for the second quarter/ half year ended 30th September 2023. Change in Venue of Board Meeting. (As Per BSE Announcement Dated on 25.10.2023) Q2 Results Approval of Q2 Unaudited standalone and unaudited Consolidated results. (As Per BSE Announcement Dated on 30/10/2023)
19-Jul-2023	28-Jul-2023	Quarterly Results	VIMTA LABS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2023 inter alia to consider and approve the standalone unaudited financial results and consolidated unaudited financial results for the first quarter ended 30th June 2023. Outcome of Board Meeting for the 1st quarter ended 30.06.2023. Standalone and Consolidated Unaudited Financial Results for the 1st quarter ended 30th June 2023. (As Per BSE Announcement dated on 28.07.2023)
24-Apr-2023	03-May-2023	Quarterly Results	VIMTA LABS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/05/2023 inter alia to consider and approve The standalone audited financial results and consolidated audited financial results for the fourth quarter and year ended 31st March 2023 and To consider and recommend the payment of Dividend if any on equity shares of the Company for the Financial Year ended 31st March 2023. Final Dividend & Audited Results (As per BSE Bulletin dated on 24/04/2023) Audited Standalone and Consolidated Financial Results for the 4th Quarter and financial year ended 31st March 2023 and Independent Auditor''s Report. Recommendation of Dividend Recommended Dividend of Rs 2 (Rupees two only) per share with face value of Rs.2 eachfor the financial year 2022-2023; subject to approval of shareholders in their ensuing Annual General Meeting Audited Standalone and Consolidated Financial Results for the 4th Quarter and financial year ended 31st March 2023 and Independent Auditor''s Report with unmodified opinion, along with a declaration by the Company in respect thereof Recommendation of Dividend Recommended the appointment of Dr. S P Vasireddi (DIN: 00242288) as Executive Chairman w.e.f. 1st July 2023 to 30th June 2026, liable to retire by rotation subject to the approval of shareholders at the ensuing 33rd Annual General Meeting. (As Per BSE Announcement Dated on 03.05.2023)
13-Jan-2023	27-Jan-2023	Quarterly Results	VIMTA LABS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2023 inter alia to consider and approve and take on record the standalone unaudited financial results and consolidated unaudited financial results for the third quarter ended 31st December 2022. Outcome of the Board Meeting. Standalone and Consolidated Unaudited Financial Results for the third quarter ended 31st December 2022, along with Limited Review Report. Standalone and Consolidated Unaudited Financial Results for the third quarter ended 31st December 2022, along with Limited Review Report. (As Per BSE Announcement dated on 27.01.2023)
17-Oct-2022	27-Oct-2022	Quarterly Results	VIMTA LABS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2022 inter alia to consider and approve interalia and take on record the standalone unaudited financial results and consolidated unaudited financial results for the second quarter/ half year ended 30th September 2022. Standalone and Consolidated Unaudited Financial Results for the second quarter / half year ended 30th September 2022, along with Limited Review Report. Standalone and Consolidated Unaudited Financial Results for the second quarter / half year ended 30th September 2022, along with Limited Review Report. (As Per BSE Announcement Dated on 27.10.2022)
13-Jul-2022	25-Jul-2022	Quarterly Results	VIMTA LABS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2022 inter alia to consider and approve the standalone unaudited financial results and consolidated unaudited financial results for the first quarter ended 30th June 2022. Standalone and Consolidated Unaudited Financial Results for the 1st quarter ended 30th June 2022, along with Limited Review Report. (As per BSE Announcement Dated on 25/07/2022)
02-May-2022	12-May-2022	Dividend	Dividend & Audited Results VIMTA LABS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2022 ,inter alia, to consider and approve Standalone audited financial results and consolidated audited financial results for the fourth quarter and year ended 31st March 2022 and recommend the payment of Dividend, if any, on equity shares of the Company for the Financial Year ended 31st March 2022. Board of Directors in their meeting held on 12.05.2022 has recommended dividend of Rs.2/- (Rs. Two only) per share with face value of Rs.2/- each for the financial year 2021-22, subject to the approval of Members in their ensuing Annual General Meeting Audited Standalone and Consolidated Financial Results for the 4th Quarter and financial year ended 31st March 2022 and Independent Auditor''s Report with unmodified opinion, along with a declaration by the Company in respect thereof. (As Per BSE Announcement dated on 12.05.2022)
10-Jan-2022	20-Jan-2022	Quarterly Results	VIMTA LABS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/01/2022 inter alia to consider and approve interalia and take on record the standalone unaudited financial results and consolidated unaudited financial results for the third quarter ended 31st December 2021. Standalone and Consolidated Unaudited Financial Results for the third quarter ended 31st December, 2021, along with Limited Review Report. (As per BSE Announcement Dated on 20/01/2022)
14-Oct-2021	23-Oct-2021	Quarterly Results	Quarterly Results VIMTA LABS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2021 ,inter alia, to consider and approve To consider, approve interalia, and take on record the standalone unaudited financial results and consolidated unaudited financial results for the second quarter/ half year ended 30th September 2021. (As per BSE Announcement Dated on 14/10/2021) Standalone and Consolidated Unaudited Financial Results for the second quarter / half year ended 30th September 2021, along with Limited Review Report. (As Per BSE Announcement dated on 23.10.2021)

1 2

LOGIN HERE

Vimta Labs Ltd

Board Meeting